The adverse prognostic impact of metabolic syndrome (METS) in unselected populations and in patients with coronary heart disease has been previously shown. The aim of the current analysis was to evaluate the impact of METS on prognosis in chronic heart failure (HF).
Prognostic impact of metabolic syndrome in patients with chronic heart failure: data from GISSI-HF trial / PERRONE FILARDI, Pasquale; Savarese, Gianluigi; Scarano, Marco; Cavazzina, Riccardo; Trimarco, Bruno; Minneci, Sergio; Maggioni, Aldo Pietro; Tavazzi, Luigi; Tognoni, Gianni; Marchioli, Roberto. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - 178:(2015), p. 85-90. [10.1016/j.ijcard.2014.10.094]
Prognostic impact of metabolic syndrome in patients with chronic heart failure: data from GISSI-HF trial
PERRONE FILARDI, PASQUALE;TRIMARCO, BRUNO;
2015
Abstract
The adverse prognostic impact of metabolic syndrome (METS) in unselected populations and in patients with coronary heart disease has been previously shown. The aim of the current analysis was to evaluate the impact of METS on prognosis in chronic heart failure (HF).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
